StonvexLoading…
StonvexStonvexStonvexCore line items from CQP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $2.66B | $3.60B | $10.76B | $7.85B | $5.44B |
Operating Income | Not available | $361.00M | $3.71B | $2.24B | $1.54B |
Net Income | Not available | $186.00M | $2.99B | $1.70B | $553.00M |
EPS (Diluted) | $0.93 | Not available | Not available | Not available | Not available |
Total Assets | Not available | $17.11B | $17.44B | $16.83B | $16.93B |
Total Liabilities | Not available | $17.03B | $17.02B | $17.18B | $17.27B |
Cash & Equivalents | Not available | $279.00M | $182.00M | $121.00M | $108.00M |
Free Cash Flow OCF − CapEx | Not available | $879.00M | $2.57B | $1.71B | $1.09B |
Shares Outstanding | Not available | Not available | Not available | Not available | Not available |